Haematologist
Víctor Jiménez-Yuste is Associate Professor of Medicine at the Universidad Autónoma de Madrid and Head of the Haematology Department at the Hospital Universitario La Paz (Madrid, Spain). After his degree in Medicine at the University of Valladolid, he specialised in haematology at the Hospital Universitario La Paz. He was awarded his PhD by the Autónoma University of Madrid where he completed his thesis studying haemophilia and HIV infection. Professor Jiménez-Yuste is a member of the executive committee of the Spanish Society of Haematology and Haemotherapy. His lines of research include the treatment of hereditary coagulation disorders, ITP, and acquired haemophilia. He has published more than 200 articles in different journals on these topics.
Bayer, BioMarin, CSL Behring, Grifols, Novo Nordisk, Octopharma, Pfizer, Roche, Sobi and Takeda.